Publications by authors named "Peter Heisig"

Claim this Profile
M
Machine learning integration of MRI and gait reveals mobility phenotypes in multiple sclerosis.
Hernan Inojosa, Wanqi Zhao, Judith Wenk, Dirk Schriefer, Stefanie Fischer, Peter Heisig

Brain Commun· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pharmacy reloaded-Comprehensive competence in all aspects of pharmaceuticals].
Ulrich Jaehde, Peter Heisig

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles.
Jan-Niklas Eckardt, Christoph Röllig, Klaus Metzeler, Peter Heisig, Sebastian Stasik

Commun Med (Lond)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning.
Jan-Niklas Eckardt, Christoph Röllig, Klaus Metzeler, Michael Kramer, Sebastian Stasik, Peter Heisig

Haematologica· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, biological evaluation, and molecular docking studies of aldotetronic acid-based LpxC inhibitors.
Stefan Wimmer, Katharina Hoff, Benedikt Martin, Martin Grewer, Laura Denni, Peter Heisig

Bioorg Chem· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibacterial activity of xylose-derived LpxC inhibitors - Synthesis, biological evaluation and molecular docking studies.
Alexander Dreger, Katharina Hoff, Oriana Agoglitta, Sven-Kevin Hotop, Mark Brönstrup, Peter Heisig

Bioorg Chem· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Emergence of Reduced Ciprofloxacin Susceptibility in Salmonella enterica Causing Bloodstream Infections in Rural Ghana.
Daniel Eibach, Hassan M Al-Emran, Denise Myriam Dekker, Ralf Krumkamp, Yaw Adu-Sarkodie, Peter Heisig

Clin Infect Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of a Novel gyrB Mutation Associated With Fluoroquinolone-Nonsusceptible Salmonella enterica serovar Typhimurium Isolated From a Bloodstream Infection in Ghana.
Hassan M Al-Emran, Anke Heisig, Denise Dekker, Yaw Adu-Sarkodie, Ligia Maria Cruz Espinoza, Peter Heisig

Clin Infect Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of Antifouling Properties of Surfaces Featuring Zwitterionic α-Aminophosphonic Acid Moieties.
Natalie Wagner, Phyllis Zimmermann, Peter Heisig, Franziska Klitsche, Wolfgang Maison

Macromol Biosci· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncomplicated Urinary Tract Infections and Antibiotic Resistance-Epidemiological and Mechanistic Aspects.
Bernd Wiedemann, Anke Heisig, Peter Heisig

Antibiotics (Basel)· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomimetic PEG-catecholates for stabile antifouling coatings on metal surfaces: applications on TiO2 and stainless steel.
Faiza Khalil, Elisa Franzmann, Julian Ramcke, Olga Dakischew, Katrin S Lips, Peter Heisig

Colloids Surf B Biointerfaces· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prominence of an O75 clonal group (clonal complex 14) among non-ST131 fluoroquinolone-resistant Escherichia coli causing extraintestinal infections in humans and dogs in Australia.
Joanne L Platell, Darren J Trott, James R Johnson, Peter Heisig, Anke Heisig

Antimicrob Agents Chemother· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia.
Joanne L Platell, Rowland N Cobbold, James R Johnson, Anke Heisig, Peter Heisig

Antimicrob Agents Chemother· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CMY-42, a novel plasmid-mediated CMY-2 variant AmpC beta-lactamase.
Moritz Hentschke, Stathis D Kotsakis, Manuel Wolters, Peter Heisig, Vivi Miriagou

Microb Drug Resist· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibacterial activity of finafloxacin under different pH conditions against isogenic strains of Escherichia coli expressing combinations of defined mechanisms of fluoroquinolone resistance.
Nadine-C Emrich, Anke Heisig, Will Stubbings, Harald Labischinski, Peter Heisig

J Antimicrob Chemother· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluoroquinolone resistance mechanisms in multidrug-resistant Escherichia coli isolated from extraintestinal infections in dogs.
Justine S Gibson, Rowland N Cobbold, Myat T Kyaw-Tanner, Peter Heisig, Darren J Trott

Vet Microbiol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Qnr and AAC(6')-1b-cr plasmid-mediated fluoroquinolone resistance determinants in multidrug-resistant Enterobacter spp. isolated from extraintestinal infections in companion animals.
Justine S Gibson, Rowland N Cobbold, Peter Heisig, Hanna E Sidjabat, Myat T Kyaw-Tanner

Vet Microbiol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alcohols for skin antisepsis at clinically relevant skin sites.
Mirja Reichel, Peter Heisig, Thomas Kohlmann, Günter Kampf

Antimicrob Agents Chemother· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type II topoisomerases--inhibitors, repair mechanisms and mutations.
Peter Heisig

Mutagenesis· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of intra- and extragenic compensatory mutations in the suppression of fluoroquinolone resistance in a Salmonella Typhimurium gyrA mutant (D87G).
Antje Preisler, Peter Heisig

J Antimicrob Chemother· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of global regulator Rma for multidrug efflux-mediated fluoroquinolone resistance in Salmonella.
Silke Feuerriegel, Peter Heisig

Microb Drug Resist· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pitfalls in efficacy testing--how important is the validation of neutralization of chlorhexidine digluconate?
Mirja Reichel, Peter Heisig, Günter Kampf

Ann Clin Microbiol Antimicrob· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Actions and resistance mechanisms of beta-lactam antibiotics. Penicillin-binding proteins, beta-3-lactamases and signal proteins].
Peter Heisig

Pharm Unserer Zeit· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of novel gyrA mutations in the suppression of the fluoroquinolone resistance genotype of vaccine strain Salmonella Typhimurium vacT (gyrA D87G).
Antje Preisler, Mobarak Abu Mraheil, Peter Heisig

J Antimicrob Chemother· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mutation in Escherichia coli DNA gyrase conferring quinolone resistance results in sensitivity to drugs targeting eukaryotic topoisomerase II.
Thomas Gruger, John L Nitiss, Anthony Maxwell, E Lynn Zechiedrich, Peter Heisig

Antimicrob Agents Chemother· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis